Breast Cancer Clinical Trial
Official title:
3-Dimensional Form and Soft Tissue Biomechanics of the Breast
The goal of this clinical research study is to characterize the 3-dimensional form and mechanical properties of the breast. Researchers want to do this in order to develop new high technology tools for improving the diagnosis and treatment of breast cancer in women.
Patients who participate in the study will have general physical and demographic information
recorded. Height, weight, age, race, menstrual status, and bra size will all be recorded.
Patients will have a breast physical exam. Researchers will then perform several painless
tests and imaging studies to evaluate the mechanical properties of the skin and the shape
and tissue composition of the breasts.
Patients in this study will go through a series of evaluations as listed below.
1. 3-D Optical Surface Scan (estimated time required: 5 minutes) The camera system with a
safe scanning laser will be used to take 3-D digitized images of the breasts and chest.
Multiple images may be necessary to get a complete rendering of both breasts. Each
image requires less than 0.6 seconds to take. This process is similar to the routine
photography currently performed on most patients.
2. Mechanical testing (estimated time required: 1 hour) A small device will be applied
with the surface of the skin at several locations on the breasts. A mild suction will
be applied for several seconds for each measurement. This will measure how the skin
tends to stretch. The instruments used are very sensitive and provide the information
needed with very small, painless amounts of movement in the skin. In addition to
evaluating characteristics of the breast skin, one additional measure will be taken on
the skin at the front of the forearm area to help understand your general skin
qualities.
3. Skin Ultrasound (estimated time required: 15 minutes) Patients will have a cutaneous
ultrasound using the 20 MHz machine and the skin thickness will be recorded in each of
the domains. A trained technician will complete this exam. In addition to evaluating
characteristics of the breast skin, one additional measure will be taken on the skin at
the front of the forearm area to help understand your general skin qualities.
4. Breast MRI and/or CT (estimated time required: 1 hour) Some patients will be scheduled
for imaging of the breasts and chest using MRI and/or CT. These images will be taken
free-of-charge as they are not required for standard of care.
Participation will be over once the evaluations are complete.
This is an investigational study. A total of 200 patients will take part in this study. All
will be enrolled at M. D. Anderson. After the first 50 patients are enrolled, the results
will be studied to see if the study will continue. All will be enrolled at M. D. Anderson.
;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |